Chief, Vascular & Endovascular Surgery
McLaren Health
Michigan State University
Bay City, Michigan, United States
Nicolas J. Mouawad, MD MPH MBA DFSVS FRCS FACS RPVI is Chief of Vascular & Endovascular Surgery at McLaren Health, Bay City, Michigan. He is Chair of the Department of Surgery, Chair of Cardiovascular Research and Medical Director of the non-invasive vascular laboratories. He is board certified in general and vascular surgery, and specializes in advanced surgical vascular care, including aortic pathologies, advanced carotid revascularization, expanded endovascular therapies, complex CLTI/PAD and venous disorders including VTE, DVT and PE.
He earned his medical degree at the Royal College of Surgeons in Ireland and completed a general surgery residency and chief residency at Trinity Health System, Ann Arbor, MI. He also completed a vascular surgery fellowship at The Ohio State University Wexner Medical Center. He has long focused as a health services professional and pursued a Master in Business Administration with a concentration in health care and hospital administration as well as a Master in Public Health with a dual focus on health policy & management and health education & promotion. He also completed the Leadership Program for Health Policy and Management at The Heller School for Social Policy and Management at Brandeis University, Waltham, MA. He was selected as the 2018 American College of Surgeons / Society for Vascular Surgery Health Policy Scholar.
Dr. Mouawad has received many honors and awards for teaching, research, and scholarship. An active clinical researcher, he is principal investigator of multiple clinical trials spanning the breadth of vascular disease. He has published more than 100 peer-reviewed articles as well as multiple book chapters. He serves on the Editorial Board of the Journal of Vascular Surgery, Annals of Vascular Surgery and Frontiers in Vascular Surgery, among others, and serves as Associate Editor for Annals in Vascular Surgery and Journal of Endovascular Therapy.
Disclosure information not submitted.
Open Thrombectomy: When and How?
Friday, May 29, 2026
8:10 AM - 8:20 AM East Coast USA Time
Access Outflow Restenosis. A Sisyphean Struggle — Anything New?
Friday, May 29, 2026
9:00 AM - 9:10 AM East Coast USA Time
Friday, May 29, 2026
9:40 AM - 10:00 AM East Coast USA Time
Are Thrombectomy Devices That Use Lytics Relevant In 2025?
Friday, May 29, 2026
2:20 PM - 2:30 PM East Coast USA Time
Friday, May 29, 2026
2:50 PM - 3:00 PM East Coast USA Time